基本信息
浏览量:2
职业迁徙
个人简介
Michele De Luca is Full Professor of Biochemistry, Director of Centre for Regenerative Medicine “Stefano Ferrari”, Director of Interdepartmental Centre for Stem Cells and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy and Scientific Director of Holostem Terapie Avanzate S.r.l., Modena, Italy.
Prof. De Luca was Scientific Director of the Veneto Eye Bank Foundation (2002-2007), Director of the Laboratory of Tissue Engineering at the Istituto Dermopatico dell’Immacolata, Rome (1996-2002), Deputy Head, Laboratory of Cell Differentiation, Istituto Nazionale per la Ricerca sul Cancro, Genova (1992-1995), Group Leader in the same Institute (1986-1992), Visiting Scientist at the Department of Cell Biology, Harvard Medical School, Boston (1985), Fogarty Fellow at the National Institutes of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK), National Institutes of Health (NIH), Bethesda (1982-1985).
He graduated M.D. in 1980 and obtained a Specialty in Endocrinology in 1984.
He is founding member of International Ocular Surface Society, member of numerous scientific societies and member of national and international commitees. He is author of more than 120 scientific publications in major international journals and author of 6 international patents. He was invited lecturer in more than 160 international meetings and symposia.
He was born in Savona, Italy, in 1956.
Michele De Luca is internationally recognized as a leading scientist in stratified epithelial stem cell biology aimed at clinical application in regenerative medicine. He played a pivotal role in epithelial stem cell-mediated cell therapy and gene therapy. Beside his pioneering work on the use of human epidermal stem cell cultures in life-saving treatment of massive full-thickness burns and in repigmentation of stable vitiligo and piebaldism, he, and his principal collaborator Graziella Pellegrini, were first in establishing human urethral epithelia stem cell cultures aimed at urethra regeneration in posterior hypospadias and human limbal stem cell culture aimed at corneal regeneration in patients with severe limbal stem cell deficiency. This latter treatment leads to recovery of vision in patients with poor alternative therapy. Michele De Luca is currently coordinating the first (successful) ex-vivo epithelial stem cell-mediated gene therapy clinical trial for the gene therapy of genetic skin diseases as Junctional Epidermolysis Bullosa. He is also studying molecular mechanisms regulating long term proliferative potential, clonal evolution and mitotic quiescence of epithelial stem cells.
研究兴趣
论文共 213 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
C. Cattaneo,E. Enzo,L. De Rosa, L. Sercia, F. Consiglio,M. Forcato,S. Bicciato, A. Paiardini, G. Basso,E. Tagliafico,A. Paganelli, C. Fiorentini,C. Magnoni, M. C. Latella,M. De Luca
MOLECULAR THERAPYno. 2 (2024): 372-383
Serena Rosignoli, Elisa Lustrino, Alessio Conci, Alessandra Fabrizi,Serena Rinaldo,Maria Carmela Latella,Elena Enzo,Gianni Prosseda,Laura De Rosa,Michele De Luca,Alessandro Paiardini
Nucleic acids researchno. W1 (2024): W29-W38
MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENTno. 3 (2024)
CELL DEATH & DISEASEno. 7 (2024)
EMBO Reportsno. 2 (2023)
引用0浏览0引用
0
0
加载更多
作者统计
#Papers: 215
#Citation: 16585
H-Index: 59
G-Index: 127
Sociability: 7
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn